In 2022, the recombinant proteins market was worth around USD 1,367.3 million, and it is projected to advance at an 11.2% CAGR from 2022 to 2030, hitting USD 3,203.7 million in 2030, according to P&S Intelligence. This development can be credited to the growing partnership between the pharmaceutical industry and universities and the increasing occurrence of primary communicable illnesses and … Continua a leggere→